Birk Möller,Lena-Luise Becker,Afshin Saffari,Alexandra Afenjar,Emanuele G Coci,Rachel Williamson,Catherine Ward-Melver,Marc Gibaud,Lucie Sedláčková,Petra Laššuthová,Zuzana Libá,Markéta Vlčková,Nancy William,Eric W Klee,Ralitza H Gavrilova,Jonathan Lévy,Yline Capri,Mena Scavina,Robert Walter Körner,Zaheer Valuvullah,Claudia Weiß,Greta Marit Möller,Moritz Thiel,Margje Sinnema,Erik-Jan Kamsteeg,Sandra Donkervoort,Veronique Duboc,Khaoula Zaafrane-Khachnaoui,Nour Elkhateeb,Laila Selim,Henri Margot,Victor Marin,Claire Beneteau,Bertrand Isidor,Benjamin Cogne,Boris Keren,Benno Küsters,Alan H Beggs,Casie A Genetti,Joost Nicolai,Jörg Dötsch,Anne Koy,Carsten G Bönnemann,Maja von der Hagen,Jürgen-Christoph von Kleist-Retzow,Nicol Voermans,Heinz Jungbluth,Hormos Salimi Dafsari

Abstract:Intracellular trafficking involves an intricate machinery of motor complexes including the dynein complex to shuttle cargo for autophagolysosomal degradation. Deficiency in dynein axonemal chains as well as cytoplasmic light and intermediate chains have been linked with ciliary dyskinesia and skeletal dysplasia. The cytoplasmic dynein 1 heavy chain protein (DYNC1H1) serves as a core complex for retrograde trafficking in neuronal axons. Dominant pathogenic variants in DYNC1H1 have been previously implicated in peripheral neuromuscular disorders (NMD) and neurodevelopmental disorders (NDD). As heavy-chain dynein is ubiquitously expressed, the apparent selectivity of heavy-chain dyneinopathy for motor neuronal phenotypes remains currently unaccounted for. Here, we aimed to evaluate the full DYNC1H1 -related clinical, molecular and imaging spectrum, including multisystem features and novel phenotypes presenting throughout life. We identified 47 cases from 43 families with pathogenic heterozygous variants in DYNC1H1 (aged 0-59 years) and collected phenotypic data via a comprehensive standardized survey and clinical follow-up appointments. Most patients presented with divergent and previously unrecognized neurological and multisystem features, leading to significant delays in genetic testing and establishing the correct diagnosis. Neurological phenotypes include novel autonomic features, previously rarely described behavioral disorders, movement disorders, and periventricular lesions. Sensory neuropathy was identified in nine patients (median age of onset 10.6 years), of which five were only diagnosed after the second decade of life, and three had a progressive age-dependent sensory neuropathy. Novel multisystem features included primary immunodeficiency, bilateral sensorineural hearing loss, organ anomalies, and skeletal manifestations, resembling the phenotypic spectrum of other dyneinopathies. We also identified an age-dependent biphasic disease course with developmental regression in the first decade and, following a period of stability, neurodegenerative progression after the second decade of life. Of note, we observed several cases in whom neurodegeneration appeared to be prompted by intercurrent systemic infections with double-stranded DNA viruses (Herpesviridae) or single-stranded RNA viruses (Ross-River fever, SARS-CoV-2). Moreover, the disease course appeared to be exacerbated by viral infections regardless of age and/or severity of NDD manifestations, indicating a role of dynein in anti-viral immunity and neuronal health. In summary, our findings expand the clinical, imaging, and molecular spectrum of pathogenic DYNC1H1 variants beyond motor neuropathy disorders and suggest a life-long continuum and age-related progression due to deficient intracellular trafficking. This study will facilitate early diagnosis and improve counselling and health surveillance of affected patients.

A Mild Case of Jeune Syndrome Associated with a Recurrent Missense Variant in DYNC2H1: Confirmation of a Genotype-Phenotype Correlation

A new case of KIAA0753-related variant of Jeune asphyxiating thoracic dystrophy

Reanalysis of Whole-Exome Sequencing Data of an Infant with Suspected Diagnosis of Jeune Syndrome Revealed a Likely Pathogenic Variant in GRK2: A Newly Associated Gene for Jeune Syndrome Phenotype

Early-onset renal dysfunction in Jeune syndrome: A case report with atypical presentation

Characterization of a novel deep-intronic variant in DYNC2H1 identified by whole-exome sequencing in a patient with a lethal form of a short-rib thoracic dysplasia type III

Missense mutation in DYNC1H1 gene caused psychomotor developmental delay and muscle weakness: A case report

VP32.04: Prenatal diagnosis a case of Jeune syndrome in combination with Down's syndrome

DYNC2H1 splicing variants causing severe prenatal short‐rib polydactyly syndrome and postnatal orofaciodigital syndrome

Prenatal Diagnosis of Myhre Syndrome in Two Cases: Further Delineation of the Cardiac and External Phenotype

Heterozygous ANKRD17 loss-of-function variants cause a syndrome with intellectual disability, speech delay, and dysmorphism

Neonatal Schwartz-Jampel syndrome type II: a rare case of peripheral origin of neonatal hypertonia

Myhre syndrome: A first familial recurrence and broadening of the phenotypic spectrum

Clinical Features and In Silico Analysis

De novo variants in ATXN7L3 lead to developmental delay, hypotonia and distinctive facial features

The expanding clinical and genetic spectrum of DYNC1H1 -related disorders

Biallelic variants in YRDC cause a developmental disorder with progeroid features

A novel GRK2 variant in a patient with Jeune asphyxiating thoracic dysplasia accompanied by Morgagni hernia

Case Report: Novel Biallelic Variants in DNAJC21 Causing an Inherited Bone Marrow Failure Spectrum Phenotype: An Odyssey to Diagnosis

Further description of two individuals with de novo p.(Glu127Lys) missense variant in the ASCL1 gene

A Rare Inherited Bone Marrow Failure Syndrome Disclosed by Reanalysis of the Exome Data of a Patient Evaluated for Cytopenia and Dysmorphic Features

A severe case of Frank-ter Haar syndrome and literature review: Further delineation of the phenotypical spectrum